COVID-19 vaccine effectiveness against SARS-CoV-2 infection in the United States prior to the Delta and Omicron-associated surges: a retrospective cohort study of repeat blood donors
View ORCID ProfileEduard Grebe, Elaine A. Yu, Marjorie D. Bravo, Alex Welte, Roberta L. Bruhn, Mars Stone, Valerie Green, Phillip C. Williamson, Leora R. Feldstein, Jefferson M. Jones, Michael P. Busch, Brian Custer
doi: https://doi.org/10.1101/2022.04.15.22273412
Eduard Grebe
1Vitalant Research Institute, San Francisco, CA
2University of California San Francisco, San Francisco, CA
3SACEMA, Stellenbosch University, Stellenbosch, South Africa
Elaine A. Yu
1Vitalant Research Institute, San Francisco, CA
Marjorie D. Bravo
4Corporate Medical Affairs, Vitalant, Scottsdale, AZ
Alex Welte
3SACEMA, Stellenbosch University, Stellenbosch, South Africa
Roberta L. Bruhn
1Vitalant Research Institute, San Francisco, CA
2University of California San Francisco, San Francisco, CA
Mars Stone
1Vitalant Research Institute, San Francisco, CA
2University of California San Francisco, San Francisco, CA
Valerie Green
5Creative Testing Solutions, Tempe, AZ
Phillip C. Williamson
5Creative Testing Solutions, Tempe, AZ
Leora R. Feldstein
6Centers for Disease Control and Prevention, Atlanta, GA
Jefferson M. Jones
6Centers for Disease Control and Prevention, Atlanta, GA
Michael P. Busch
1Vitalant Research Institute, San Francisco, CA
2University of California San Francisco, San Francisco, CA
Brian Custer
1Vitalant Research Institute, San Francisco, CA
2University of California San Francisco, San Francisco, CA
Data Availability
Blood donation data are not publicly available, but any reasonable requests to the authors will be afforded due consideration, in line with applicable blood center policies and legislation.
Posted April 16, 2022.
COVID-19 vaccine effectiveness against SARS-CoV-2 infection in the United States prior to the Delta and Omicron-associated surges: a retrospective cohort study of repeat blood donors
Eduard Grebe, Elaine A. Yu, Marjorie D. Bravo, Alex Welte, Roberta L. Bruhn, Mars Stone, Valerie Green, Phillip C. Williamson, Leora R. Feldstein, Jefferson M. Jones, Michael P. Busch, Brian Custer
medRxiv 2022.04.15.22273412; doi: https://doi.org/10.1101/2022.04.15.22273412
COVID-19 vaccine effectiveness against SARS-CoV-2 infection in the United States prior to the Delta and Omicron-associated surges: a retrospective cohort study of repeat blood donors
Eduard Grebe, Elaine A. Yu, Marjorie D. Bravo, Alex Welte, Roberta L. Bruhn, Mars Stone, Valerie Green, Phillip C. Williamson, Leora R. Feldstein, Jefferson M. Jones, Michael P. Busch, Brian Custer
medRxiv 2022.04.15.22273412; doi: https://doi.org/10.1101/2022.04.15.22273412
Subject Area
Subject Areas
- Addiction Medicine (370)
- Allergy and Immunology (689)
- Anesthesia (184)
- Cardiovascular Medicine (2748)
- Dermatology (235)
- Emergency Medicine (414)
- Epidemiology (12398)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4259)
- Geriatric Medicine (396)
- Health Economics (699)
- Health Informatics (2757)
- Health Policy (1018)
- Hematology (369)
- HIV/AIDS (879)
- Medical Education (404)
- Medical Ethics (112)
- Nephrology (453)
- Neurology (4036)
- Nursing (216)
- Nutrition (598)
- Oncology (2126)
- Ophthalmology (604)
- Orthopedics (251)
- Otolaryngology (312)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (478)
- Pediatrics (1148)
- Primary Care Research (468)
- Public and Global Health (6652)
- Radiology and Imaging (1446)
- Respiratory Medicine (886)
- Rheumatology (421)
- Sports Medicine (353)
- Surgery (464)
- Toxicology (57)
- Transplantation (192)
- Urology (171)